Area of research
Pathology and Forensic Medicine · Surfaces, Coatings and Films
Research interest
Research focused on China and Lysosome, with related work in CHOP, Workload, Epidemiology. Notable publications include 'Obesity induces preadipocyte CD36 expression promoting inflammation via the disruption of lysosomal calcium homeostasis and lysosome function', 'Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma: An open-label, randomized, multicenter phase II/III trial', and '5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patients'.
Identification of Monocyte CD11c as a Potential Biomarker for Distinguishing Sepsis From Non-Infectious Inflammation and Predicting the Outcome of Sepsis
Clinical outcomes and therapeutic modalities in older Chinese patients with MCL: a multi-center real-world retrospective study
Chromosome-level genome assembly of Turpan wonder gecko (Teratoscincus roborowskii) reveals olfactory candidate genes
PDIA3 orchestrates effector T cell program by serving as a chaperone to facilitate the non-canonical nuclear import of STAT1 and PKM2
MRI Radiomics Nomogram for Predicting Disease Transition Time and Risk Stratification in Preclinical Alzheimer's Disease
Epidemiological characteristics, clinical presentations, and prognoses of pediatric brain tumors: Experiences of national center for children’s health
Real‐world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis
Berberine Reverses the Tumorigenic Function of Colon Cancer Cell-Derived Exosomes
Additional file 13 of Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low
Additional file 10 of Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low
Additional file 8 of Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low
Additional file 14 of Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low
Additional file 12 of Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low
5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patients
Work-Related Musculoskeletal Disorders Among Hospital Midwives in Chenzhou, Hunan Province, China and Associations with Job Stress and Working Conditions
Obesity induces preadipocyte CD36 expression promoting inflammation via the disruption of lysosomal calcium homeostasis and lysosome function
Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma: An open-label, randomized, multicenter phase II/III trial.
Safety and effectiveness of apatinib in patients with previously treated metastatic gastric cancer: a sub-analysis from the real-world study of apatinib for gastric cancer treatment (AHEAD-G202).
PubMed 2020cited by 15position: middle
Facile conjugation of heparin onto titanium surfaces via dopamine inspired coatings for improving blood compatibility
Responses of platelets and endothelial cells to heparin/fibronectin complex on titanium: In situ investigation by quartz crystal microbalance with dissipation and immunochemistry